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INTRODUCTION 
 
Advances in modern health care have led to increase in geriatric 
population. The annual growth rate of people more than 60 years is faster than 
any other age group. Aging is associated with renal structural changes and 
functional decline. As life expectancy increases, the prevalence of elderly 
patients living with renal diseases is more. The biology of aging with associated 
co morbid illness like diabetes, hypertension, cardiovascular disease often 
modify the clinical presentations, pathological findings and natural history of 
renal disease in the elderly. The incidence of glomerular disease in elderly is 
varies in different population from 5 to 20% and it is ever increasing. Due to 
aging, co morbid illnesses and blunted immune response, clinical presentations 
are often atypical. Renal biopsy is the gold standard for diagnosing glomerular 
diseases, yet less than 15% renal biopsies were from age more than 60 years. 
This leads to under diagnosis and delay in treatment. The studies on geriatric 
nephrology in India are limited, that too in glomerular diseases were scarce. We 
intend to study the spectrum of glomerular diseases in the elderly and its clinico 
pathological correlation.  
 
2 
 
 
 
 
AIMS 
 
To study the clinico pathological spectrum of glomerular diseases 
in elderly patients and their outcomes. 
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REVIEW OF LITERATURE 
In India, the cut off for definition for elderly individual is 60 years. 
According to 2011 population census, elderly constitutes about 10 % of Indian 
population, which is high when compared to 7.5 % in 2001 data and it is 
projected to increase up to 20% in the year 2050[1]. This could be attributed to 
improved health care delivery systems and better hygiene. In a developing 
country like India, it will pose pressures in socioeconomic front including health 
care. Yet this progress is hampered by increased prevalence of non 
communicable diseases like hypertension and diabetes, causing high incidence 
coronary artery disease and chronic kidney disease. The prevalence of 
glomerular diseases is increasing in elderly population in accordance to 
increased survival, but there is a tendency in treating physicians to manage 
conservatively in view of multiple co morbid illness. As a result, elderly 
patients with renal disease are often without specific diagnosis and disease 
specific treatment to slow the rate of progression.   
The recognition, diagnosis and management of glomerular diseases in 
elderly population throw several unique challenges[2]. In an elderly individual 
the reduction in glomerular filtration rate (GFR) in the setting of aging 
nephropathy and vascular disease, an intrinsic renal disease is often overlooked. 
In a Meta analysis by O’Hare et al have shown that aging nephropathy per se is 
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not usually associated with proteinuria[3]. So presence of proteinuria or active 
urine sediments should be considered as a presence of renal disease rather than 
age related reduction in GFR. On the contrary, urinary abnormalities and 
reduction in GFR is often erroneously attributed to aging kidney and are not 
investigated any further causing difficulty in recognition and treatment of 
glomerular diseases in an elderly individual. Recent studies have reported that, a 
significant number of patients have unexpected glomerular diseases in elderly 
and may benefit from treatment which might not otherwise be considered [4]. 
Aging:  Is it Physiological or Pathological? 
Aging is a natural and inevitable biological process in human evolution. 
The kidneys undergo anatomic and physiologic changes due to aging, which 
may be exaggerated by some diseases (atherosclerosis/diabetes) that occur in 
high frequency in elderly. The constellation of glomerulosclerosis, 
arteriosclerosis, interstitial fibrosis and tubular atrophy constitutes 
nephrosclerosis in the aging kidney. Number of studies have shown the 
increased proportion of glomerulosclerosis with aging [5] [6] [7]. They were 20%, 
38%, 47%, 65%, 76% & 82% in 3rd, 4th, 5th, 6th, 7th and 8th decades respectively. 
Aging glomeruli has an ischemic appearance due to tuft collapse and 
intracapsular fibrosis favouring primary vascular cause of lesions. The 
functioning glomeruli  also has an  ischemic capillary wrinkling of tuft, 
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basement membrane thickening which leads to ischemic shrinkage of tuft and 
filling of bowman’s space with collagen deposits in due course. With the 
sclerosis of juxtamedullary glomeruli, there will be a direct connection between 
afferent and efferent arteriole, bypassing the tuft, causing aglomerular tuft. The 
sclerotic glomeruli are smaller than functioning glomeruli, which contributes to 
average small size of glomeruli, but there will be compensatory hypertrophy of 
remaining functioning glomeruli. Thus in an aging kidney, both increase in 
proportion of smaller sclerosed glomeruli and a minor fraction of larger 
functioning glomeruli may occur [8]. 
 Aging Nephropathy is characterized by loss of GFR by about 
1.7ml/min/year. Creatinine clearance is influenced by nutritional status, protein 
intake and muscle mass and hence it is not an accurate measure of GFR in the 
elderly [9]. The generation of creatinine and its urinary excretion gradually 
decline in proportion to age related decrease in body weight and muscle mass. 
Thus serum creatinine does not increase despite age related reduction in 
creatinine clearance. Though the ‘true GFR’ measured by inulin clearance is 
significantly lower in elderly when compared with younger ones, it is within 
normal range. Creatinine clearance under estimates GFR in elderly and when 
measured by Cockroft-Gault (CG) formula, it is even lower. The modification 
of diet in renal disease (MDRD) study group formula is considered more 
accurate than CG formula in elderly [10]. But neither CG nor MDRD formula has 
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been validated in age group more than 70 years. MDRD equation generally 
yielded higher estimated GFR than CG formula. The important implication of 
this is in calculating drug dosing in elderly. Overestimation of GFR by MDRD 
formula can cause inadvertent drug over dosage. Thus it is recommended that 
CG formula should be used in preference to MDRD equation to estimate GFR 
to calculate drug dosing in the elderly patients [11]. Serum Cystatin C is a 
promising index to estimate GFR in renal insuffiency in elderly. 
Aging affects renal tubular function in many ways. The fractional sodium 
reabsorption is significantly higher in proximal tubule but it was offset by less 
fractional reabsorption of sodium in distal tubules. In diet with salt deprivation, 
aging kidney is not able to conserve sodium due to significant slowing down of 
physiological response to conserve sodium by reduction  in urine fractional 
excretion. Thus elderly population is more prone for volume depletion. The 
defect in potassium handling is due to age related tubulo interstitial changes 
causing impaired potassium secretion and corresponding impaired sodium 
reabsorption. This explains the increased susceptibility of elderly population to 
hyperkalemia. The impaired ability of the aging kidney to concentrate or dilute 
the urine to its maximum capacity makes them vulnerable to dehydration, 
hypernatremia, nocturia and hyponatremia when excess fluid is administered[12]. 
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An important implication of aging kidney is on drug metabolism. There 
are number of reasons for increased susceptibility to drug toxicity in elderly. 
The reduction in excretory capacity of aging kidney, decline in hepatic 
metabolism, altered body composition (reduced water content, increased fat) 
causes changes in pharmacokinetics of the drug. Aging adversely affects 
pharmacodynamics by modulating the sensivity and physiological response to 
their actions. The combination of altered pharmacokinetics and 
pharmacodynamics in the elderly patients on poly pharmacy in addition to co 
morbid conditions makes the management more complex. Therefore it is 
prudent to initiate the therapy at drug dosage at lowest effect and increase the 
dose slowly [13]. 
ROLE OF RENAL BIOPSY 
Renal biopsy is considered as the gold standard in glomerular diseases. It 
helps in accurate diagnosis, picks up prognostic indicators like features of 
chronicity and devising treatment plan. Though the first renal biopsy done by 
Iversen has come long way, in a study by Nair et al, elder patients made up just 
4.2% of total biopsy. This number is lower when compared other age groups [14]. 
There are still controversies regarding necessity and complications of doing 
renal biopsy in elderly. Previous studies have reported the differences in the 
indications for renal biopsy between the elder age group and younger ones [15]. 
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In young adults and children, nephrotic syndrome is the main indication, where 
as in the elders, main indication is acute kidney injury.  Renal biopsy is not 
routinely done in elderly because of medical condition at time of evaluation and 
difficulty in analyzing risk benefit ratio of doing biopsy. Recent articles have 
proved that not only biopsy is safe in elderly but also necessary in making 
diagnosis as well as appropriate therapy, because of atypical presentation in 
elderly [16][17]. In study by Hass et al showed that in elderly patients, prebiopsy 
diagnosis was correct only in 33% and biopsy made specific diagnosis in 90% 
patients and a diagnosis offering the potential for treatment in improving the 
outcomes made in 73% patients. In study by Moutzouris et al 67% of patients 
had biopsy findings that are potentially amenable to therapy [18]. That includes 
acute kidney injury, acute interstitial nephritis, thrombotic microangiopathy, 
pauci immune glomerulonephritis, nephrotic syndrome, light chain diseases etc. 
Many of the elderly patients may have significant co morbid illness that would 
limit the ability to treat the illness aggressively. So not all patients with 
potentially amenable renal disease will receive specific therapy. Even in patients 
whom biopsy does not modify the therapy, it gives prognostic value and 
eliminates the need for potentially harmful empirical cytotoxic therapy. 
 
 
9 
 
GLOMERULAR DISEASES IN ELDERLY: 
In the elderly, secondary glomerular disease due to a systemic disease is 
more common than primary glomerular disease. The most common cause of 
secondary glomerular disease in developed and developing countries are pauci-
immune necrotizing glomerulonephritis and post infectious glomerulonephritis 
respectively. Various studies have reported crescentric GN occurs in higher 
frequency and mesangial nephritis in lower frequency among the elderly when 
compared young adults [19] [20].Similarly minimal change disease and 
membranoproliferative GN were common in children and adults, where as pauci 
immune GN and membranous nephropathy were common in elderly.  
MEMBRANOUS NEPHROPATHY: 
Membranous nephropathy (MN) is the most common cause of idiopathic 
nephrotic syndrome in older adults, accounting for 20% of cases. Though 30% 
patients undergo spontaneous remission, 40% patients will reach end stage renal 
disease at end of 10 years [21].20% patients can have secondary cause including 
infection, malignancy, auto immune disease and drug intake. Membranous 
nephropathy is characterized by sub epithelial immune deposit which causes 
membrane like thickening around glomerular basement membrane. The immune 
deposit consists of IgG mainly of IgG4 and IgG1 against M type phospholipase 
A2 receptor in the podocyte (PLA2R). 
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Beck et al made a path breaking discovery that, in human idiopathic 
membranous nephropathy, sub epithelial immune deposits form insitu by 
binding of circulating anti PLA2R antibodies against PLA2R antigen expressed 
on the podocyte. Since 70% patients with idiopathic membranous nephropathy 
have serum anti PLA2R antibodies detected, it serves as a valuable tool in 
diagnosis as well as follow- up of patients [22]. 
The risk factors for progression of MN include old age at presentation, 
male sex, nephrotic range of proteinuria, renal failure at presentation and degree 
of tubulo interstitial disease on renal biopsy. Cattran et al has proposed a 
prognostic model to predict disease progression dividing into three groups. Low 
risk includes those with normal renal function and less than 4gms of proteinuria 
in clinical course over 12 months. Medium risk for renal disease progression 
includes stable renal function with proteinuria between 4-8gms over 9 months. 
High risk group is defined by presence of renal dysfunction at presentation or 
during observation with proteinuria of more than 8 gms over a period of 6 
months. This group has 75% risk of disease progression[23].  
In MN, patients with low to medium risk were typically treated with ACE 
inhibitors or ARBs with statins. Despite conservative measures, if proteinuria 
persists for more than 6 months, immunosupression is advocated. High risk 
patients with impaired or declining renal function, patients with complications 
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of nephrotic syndrome are treated with cytotoxics promptly. Ponticelli et al 
recommends 6 months regime of alternating steroids with alkylating agents with 
proven short term and long term benefits. This regime achieved remission rate 
of about 76%, relapse rate of 25% and 10 year renal survival rate of 
92%.calcineurin inhibitors are second line of drugs for those not responded with 
Ponticelli regime[21]. 
The management of MN in elderly is difficult in view of their age, co 
morbidities and late presentation. Renal survival is worse for patients with 
elderly MN.The studies on elderly MN is limited since majority of trials has 
excluded old age[24]. Given that advancing age and side effects of cytotoxics 
drugs, decision should be individualized in each patient after risk/benefit 
analysis. Management of glomerular diseases in elderly: 
The management and evaluation of glomerular diseases and its associated 
manifestations similar in all age groups. The primary etiology of nephrotic 
syndrome should be the principle guide for therapy. Older individuals may be 
sensitive to diuretic therapy and develop pre renal azotemia and more prone for 
electrolyte imbalances. Hence they need cautious dosing and careful follow up. 
Pharmacokinetics of the may be affected by reduced lean body mass, 
diminished hepatic and renal clearance. 
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Post Infectious Glomerulonephritis: 
PIGN is the most common cause of glomerulonephritis in the developing 
world. There has been shift in epidemiology as well as outcomes in recent 
decades. There has been change in the age predominace, four decades back less 
than 6% were elderly, compared with 34% in a recent study[25]. This is likely 
due to increased life expectancy, high frequency of infection in adults and 
higher prevalence of diabetes. Apart from diabetes, other predisposing factors 
for PIGN are alcoholism, synthetic heart valve, malignancy, I V drug abuser etc. 
The site of infection in children and adults includes upper respiratory tract and 
skin, but in elderly group infective sites includes skin, teeth, lung, urinary tract, 
bone and visceral abscess. The two most commonly identified organisms were 
streptococcus and staphylococcus. Streptococcus is still most common organism 
in the developing world, whereas staphylococcus aureus is as common as 
streptococcus in developed countries[26]. Gram negative organisms accounts for 
10% infections. In contrast to children, significant proportion of adults have no 
latent period, 45% have evidence of infection at the time of renal disease. In 
both children and adults, symptomatic patient typically present as acute 
nephritic syndrome with new onset haematuria, proteinuria and 
hypertension..The presence age related illness like Hypertension and diabetes 
alters the clinical picture of PIGN in elderly. The new onset or exacerbation of 
congestive cardiac failure is common in elderly because, in the setting of 
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underlying cardiac dysfunction with reduce ability to handle salt and water 
retention. Hypertension is present in 60-84% of elderly population at 
presentation. Presentation with seizures and hypertensive encephalopathy are 
rare with elderly unlike children. 25 to 30% can have nephrotic range of 
proteinuria. In a study on PIGN in elderly,67% presented with serum creatinine 
of more than 4mg/dl, 50% had gross microhaematuria,50% required dialytic 
support, 60% had leucocyturia, 30-80% can have low complement levels.30% 
had low C3 & C4. 70% have normal C4 and low C3[25][27].Usually complements 
return to normal range within 2 months. Serology for ANCA may be positive in 
about 8% elderly PIGN, particularly in infective endocarditis associated GN 
where it may increase up to 25% and contributes to diffuse and necrotizing 
crescents[26]. In the light microscopy, diffuse endocapillary proliferation with 
numerous intracapillary neutophills is the most common histological pattern 
seen in about 70%, focal endocapillary and mesangial proliferation can also 
seen in patients on resolving phase. About 25% of biopsy can have focal 
crescents (< 30%), in about 5 % of patients, more than 50% crescents can also 
be seen. Immunoflourescence typically reveals dominant C3 deposits. Three 
types IF pattern seen in PIGN. Coarse granular staining involving predominant 
glomerular capillary wall called “Garland Pattern” implies severe type of 
lesions, frequently associated with nephrotic range of proteinuria. The second 
type involves predominant staining of both mesangium and glomerular 
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capillaries called “Starry Sky pattern”. The third type is “mesangial” pattern 
which stains only mesangium, seen in resolving phase. Isolated C3 deposits may 
be seen in 30%, 25 % can have typical full house pattern staining for Ig M, Ig 
G, Ig A, C1q.Electron Microscopy reveals ‘hump shaped’ deposits in the 
subepithelium. Recently elderly patients with PIGN, intense staining for Ig A is 
the dominant IF, with mesangial and sub epithelial deposits. All patients were 
associated with hypocomplementemia, diabetic nephropathy and staphylococcal 
infection. This new entity called IgA dominant PIGN is increasingly recognized 
in up to 17% of elderly PIGN have rapid progression to CKD and poor 
prognosis [28]. 
One important differential diagnosis of PIGN is C3 Glomerulopathy 
(C3G).It is a newly recognized entity characterized by MPGN pattern in light 
microscopy with dominant C3 deposits in the IF, which is due to abnormalities 
in the alternate pathway in the complement activation. Isolated C3 deposits can 
be found is 25% patients with PIGN. Hence differentiating C3G from PIGN 
requires clinical, laboratory and histopathological correlation. The factors 
favouring C3G are 1. Lack of clinical evidence of infection 2.MPGN pattern in 
light microscopy 3. Persisting signs of active glomerulonephritis 4. Persistent 
low C3 levels for several months 5. Presence of intramembranous and sub 
endothelial deposits [29][30]. The treatment of PIGN includes eradication of 
infective foci if any found and management of acute nephritic syndrome. It 
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includes salt restriction, antihypertensive and diuretics. The role of steroids and 
other immunosupression in the elderly is controversial. There are only anecdotal 
reports supporting role of steroids in the management of crescentric PIGN. In 
children PIGN had a very good prognosis with complete recovery. But in 
elderly patients, 30-55% can have persistent renal dysfunction, 3-30% develops 
ESRD[31][32].The independent risk factors for persistent renal failure in PIGN 
includes older age, high creatinine at presentation, diabetic glomerulosclerosis, 
presence of tubulointerstitial scarring, presence of co morbid conditions like 
diabetes, malignancy etc. There are various theories on pathogenesis of PIGN. 
1. Immune complex deposition 2. Localization of bacterial cationic antigen 
within the subepithelium, which forms in situ immune complexes 3. Molecular 
mimicry of bacterial antigen to glomerular antigen causing complement 
activation [33]. The evidence supporting circulating immune complex deposition 
are demonstrated in cases of shunt nephritis and endocarditis related GN where 
circulating immune complexes gets entrapped in glomeruli. But the concept of 
in situ immune complex has gained acceptance because bacterial cationic 
antigens easily get past the GBM, which incites antibody deposits within sub 
epithelium. The evidence for molecular mimicry is demonstration of antibodies 
against nephritogenic strain M12 which cross reacts with glomerular 
components of collagen, laminin. The two leading  candidate streptococcal 
antigens are glyceraldehyde 3-phosphate dehydrogense (GADPH),a plasmin 
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receptor and streptococcal exotoxin-B(Spe-B), a cationic proteinase which acts 
as a virulent factor by blocking opsonization.GADPH co localizes within 
glomeruli by its plasmin binding capacity. The locally activated plasmin 
degrades GBM and activates inflammatory pathway and facilititates binding of 
neutrophills to capillary endothelium. Spe-B penetrates GBM and co localize 
with complements and causes immune mediated renal injury [34]. In IgA 
dominant GN, staphylococcal enterotoxin acts as a super antigen, which binds 
to MHC class 2 molecules without any internal processing and causes massive 
T cell activation. The other two highly cationic antigen implicated were 
staphylococcal P70 protein and staphylococcal neutral phosphatase [35]. In a very 
recent study of 11 patients with persistent atypical PIGN, antibodies against 
alternate complement pathway has been demonstrated which causes persistent 
activate alternate complement pathway causing injury [29]. The authors propose 
streptococcal infection unmasks the dysregulation of alternate complement 
pathway causing C3 glomerulopathy. 
VASCULITIS: 
The systemic vasculitides characterized by leucocytic infiltration of blood 
vessels, fibrinoid necrosis associated with vascular damage. They could be 
either primary or secondary to auto immune disease, drugs and malignancy. In 
primary systemic vasculitis the antibodies to neutrophillic cytoplasmic antigens 
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[ANCA] are the most prevalent, which affects the small vessels. The vasculitis 
affecting the small blood vessels are classified as 
 
1. Granulomatosis with polyangiitis (formerly Wegener’s)-GPA 
2. Microscopic polyangiitis- MPA 
3. Churg-Strauss Syndrome-CSS 
4. Henoch –Schonlein Purpura-HSP 
5. Cryoglobinemic vasculitis 
6. Cutaneous leucocytoclastic vasculitis 
 
ANCA Associated Vasculitis (AAV) is the most common cause of 
rapidly progressive glomerulonephritis in the elderly population worldwide. It 
predominately affects the age group between 60-75 years. The renal 
involvement is associated with significant mortality and morbidity, with 
mortality rate as high as 60% at end of one year[37]. 
Though the pathogenesis is similar for all the types, they differ in their 
histopathology and clinical features. Granuloma formation in the affected vessel 
is a feature of GPA & CSS, but not MPA. Abundance of neutrophills is a 
dominant feature of GPA whereas much of the inflammatory infiltrate in CSS is 
18 
 
due to eosinophills.  Most of the antibodies are directed against PR-
3(Proteinase) in patients with GPA. CSS & MPA are associated with ANCA 
directed against MPO (Myeloperoxidase).GPA associated 70% PR3 and 25% 
MPO ANCA positivity; MPA is associated with 50% MPO & 40% P ANCA 
positivity; CSS is associated 40% MPO,30% P ANCA positivity respectively. 
Pathogenesis of AAV: 
ANCA by itself can cause vasculitis, but it’s interaction with neutrophills 
and vascular endothelium is implicated as major mechanism for pathogenesis. 
Binding of ANCA to membrane bound PR3/MPO neutrophills causes activation 
and release of proteases and super oxides. Infection, environmental factors 
triggers stimulate release of cytokines like TNF-α and IFN-γ which causes 
translocation of PR3/MPO within neutrophillic granules to membrane. This 
process is called “Priming”. ANCA also increases the expression of adhesion 
molecules like ICAM, VCAM in the vascular endothelium. Priming of 
neutrophills also increases the adhesion of neutrophills to vascular endothelium. 
So once degranulation occurs in close contact with endothelium, it causes 
vasculitic damage to the endothelium.this theory is proved by animal model of 
AAV by rat model of MPO ANCA. So far no animal model for PR3 ANCA has 
been established. Recently Pendergraft et al proposed theory of complementary 
peptides to explain the pathogenesis of GPA. The hypothesis is that the initial 
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immune response is against complementary protein PR3(cPR3). The antibodies 
against cPR3 serve as a antigenic target that evokes secondary immune response 
(anti-idiotype antibodies). These antibodies not only against anti cPR3 
antibodies, but also against PR3 antigen. The pathogens like staph aureus bear 
genetic sequences that are similar to human PR3 gene[38]. This explains why the 
chronic nasal carrier state of staph aureus provokes vasculitic relapse. About 
20% patients with features of vasculitis were ANCA negative. Kain et al 
recently proposed LAMP-2 antibodies (Lysosomal membrane 
protein).Antibodies against infections with Gram negative organisms carrying 
fimbriae cross reacts with lysosomal membrane protein[37]. 
The role of T cells should be undermined in AAV. In Vascultis T cells 
are in constant activation, there is expansion of both memory (Tems) and 
decrease in naïve T cells. Tems cells are powerful in initiating and sustaining 
immune response. Kessenbrock et al reported formation of neutrophills 
extraellular traps (NET’s).they are decondensed chromatin fibres containing  
PR3,MPO,Elastase which  acts as a host defense to trap these antigens. But 
these modified DNA’s are recognized as DAMP’s (Danger associated 
Molecular pattern) by dendritic cells which stimulates Toll like receptors 
(TLR).This activates immune response [39] . 
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Treatment of AAV: 
European league against Rheumatism (EULAR) has recently published 
guidelines for management of AAV. It recommends induction regime& 
maintenance therapy. They categorized into 5 types according to the 
involvement as localized, early systemic, generalized, severe and refractory. For 
induction, EULAR recommends localized /early systemic should be treated with 
oral steroids and methotrexate. Generalized vasculitis implies renal involvement 
with creatinine level less than 5.5mg/dl. EULAR recommends 
cyclophosphamide (oral or IV) in combination with steroids. Renal involvement 
with serum creatinine level of more than 5.5 mg/dl is categorized under severe 
form. Recommended treatment is plasma exchange. Those disease category 
which does not achieve remission following cyclophosphamide were classified 
as refractory and EULAR recommends rituximab. 
Induction therapy: 
In systemic vasculitis should initially be treated with combination of 
cyclophosphamide and steroids. Cyclophosphamide can be given as IV, 3 doses 
every 2 weeks, then 7 doses every 3 weeks or low dose, continuous oral for 
maximum of six months. IV cyclophosphamide has distinct advantage in terms 
of less cumulative dose, better bladder protection, better compliance with 
slightly increased risk of relapse. The efficacy of IV cyclophosphamide is 
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proven by CYCLOPS trial [40]. Patients presenting with severe renal failure are 
at high risk of ESRD and death. In MEPEX trial done in 134 patients, both arms 
received oral cyclophosphamide and steroids. Adjunctive therapy of plasma 
exchange or IV methyl prednisolone was tried. Plasma exchange results in 20% 
more dialysis independency and 24% less progression to ESRD 12 months [41]. 
Two trials (RAVE & RITUXVAS) provide evidence that rituximab 
/prednisolone combination is not inferior to cyclophosphamide in inducing 
remission [42][ 43].  
Maintenance therapy: 
Maintenance therapy in AAV is must considering the risk of relapse. 
EULAR recommends therapy of 18-24 months. In view of toxicity of 
cyclophosphamide, it is no longer considered for long term therapy. 
Azathioprine is the first line drug of choice for maintenance therapy in AAV. Its 
efficacy is as good as cyclophosphamide as proved by CYCAZAREM trial. The 
dose is 2mg/kg/day. 
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Outcomes: 
The relapse rate at 2 years is 18-60 in GPA, 8% in MPA. At 5 years, the 
risk of relapse is 50% in case of GPA. The factors which increase the risk of 
relapse are nasal carriage of Staph aureus, upper respiratory tract involvement 
and PR3 ANCA positivity [44]. The factors which predict resistance include 
female sex, black race and severe renal involvement. The mortality rate was 
20% within first year of diagnosis, around 25% reach ESRD within 4 years. 
These outcomes are more worsen among elderly individuals [45]. 
Renal biopsy is the gold standard for establishing the diagnosis of AAV. 
Light microscopy typically shows focal and necrotizing crescentric 
glomerulonephritis. It is characterized by little or no immune deposits for 
complements and immunoglobulins, hence described as pauci immune GN. In 
electron microscopy, there will be subendothelial swelling, microthrombosis 
and degranulated neutrophills, but no immune deposits. 
Recently histopathological classification of AAV based on glomerular 
pathology in light microscopy has been published and is of prognostic value in 
predicting 1year and 5 year renal outcomes. 
Focal :        ≥ 50% glomeruli normal 
Crescentric: ≥ 50% glomeruli with cellular crescents 
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Mixed :     < 50% glomeruli normal, < 50% crescentric, < 50% globally 
sclerotic glomeruli 
Sclerotic:    ≥ 50% with globally sclerotic glomeruli 
The renal survival rate for focal, crescentric, mixed and sclerotic at 1year 
and 5 year  are as follows, 93 & 99 %(focal),84 & 76%(crescentric),69& 
61%(mixed),50 &25%(sclerotic)[46]. 
The studies in AAV in elderly patients demonstrated poor prognosis with 
significant high mortality rate, ESRD and treatment related complications when 
compared to younger counterparts. 
Renal failure in myeloma: 
It occurs in 20-40% of newly diagnosed multiple myeloma, may provide 
clue for diagnosis and causes significant morbidity. Renal failure results from 
toxic effects of monoclonal chains, mainly on renal tubules and glomeruli. The 
renal manifestations of myeloma can also cause Amylodosis[AL],light chain 
disease, heavy chain disease,tumour lysis syndrome. The contributory factor for 
renal failure includes dehydration, hypercalcemia, drugs, NSAIDS, antibiotics, 
diuretics and contrast agents. Nearly 500mg of light chains are produced every 
day and only 10 mg appear in urine, majority of them being catabolised at the 
level of proximal tubule. In plasma cell disorders capacity of proximal tubule is 
overwhelmed and free light chains which excreted in urine is called as Bence 
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Jones proteins. Free light chains can cause proximal tubular injury and cast 
nephropathy or combination of both. 
Free light chains are directly toxic to proximal tubule cell causing 
defective absorption of glucose, aminoacids, and phosphate. The most important 
toxic effect is due to excessive endocytosis of light chains through cubilin-
megalin receptor which activates redox pathway, increased expression of 
nuclear factor B and mitogen activated receptor kinases which induces 
inflammatory cytokines like IL-6,TGF-β and monocyte chemoattractant 
protein.the final common pathway is triggering of apoptosis and epithelial-
mesenchymal transistion. Another mechanism of light chain mediated tubular 
damage is due to the intratubular obstruction in the distal lumen. Large amount 
of free light chain reaching distal tubule interacts with Tammhorsfall protein 
secreted by thick ascending limb of loop of Henle. Complement determining 
region of free light chains (CDR domain) combine with THP  forming the cast. 
The cast formation is dictated by ionic composition of tubular fluid, amount of 
light chains and THP, presence of frusemide. the intratubular obstruction 
increases proximal tubular pressure and reduction of single nephron GFR. The 
cast formation also elicits giant cell formation around tubules. 
Renal biopsy in patients with monoclonal gammapathy and renal failure 
is valuable to determine type of renal injury, its chronicity, nature of 
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pathological process and planning aggressive therapy if warranted. In a patient 
with monoclonal gammapathy with acute kidney injury, the most common renal 
lesion is cast nephropathy. The other conditions which mimic AKI include AL 
amyloidosis. Immunoflourescence plays a key role in making definitive 
diagnosis of plasma cell dyscrasia. The staining for κ and λ chains and careful 
evaluation of Ig chains helps to determine isotypic restriction of light and heavy 
chains. (amyloids stains predominantly λ chains, while light chains stains κ). 
Renal failure in myeloma is mild to moderate. 8% patients require 
dialysis. Goal of therapy in myeloma kidney is to reduce the lightchain exposure 
to kidney and to prevent its interaction with THP. The antimyeloma therapy 
includes combination of high dose dexamethasone with thalidomide, 
lenalidomide or proteosomal inhibitor bortezomib. Direct removal of FLC by 
plasma change is highly attractive method to rapidly reduce the serum 
concentration of light chains.but plasma exchange removes very little 
extravacular light chains with more loss of essential immunoglobulins and 
coagulation proteins.another novel method is use of High Cut off dialyzer  to 
remove light chains. This membrane with diameter of 50kDa provides rapid 
clearance of κ & λ chains. The combination of high cutoff dialyzer with 
chemotherapy achieves renal response rate in 60 -75% patients. 
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AMYLOIDOSIS: 
Amyloidoses are group of disorders characterized by precipitation of 
extracellular,pathologic,insoluble fibrils of size 8-10nm  in various tissues and 
organs. All deposited fibril have specific β pleated structure which stains apple-
green birefringence with congo red dye when exposed under polarized light. In 
all type of Amyloidosis,the glycosaminoglycans and serum amyloid 
protein(SAP) interact together to confer stability for the fibrils. Amylodosis is 
classified on the basis of its distribution and amyloidogenic protein. In systemic 
amyloidosis the fibrils are produced at distant site from its deposition and in 
local amyloidosis, it is produced in the site of its deposition. Light chain 
amylodosis (AL) is the most common form of systemic amylodosis. The 
amyloidogenic protein in AL amylodosis is Ig light chain or a fragment of light 
chain produced by clonal plasma cells in the bone marrow.they produce more κ 
isotope than λ in the ratio of 3:1.The plasma cell burden in AL amylodosis is 
about 5-10%. In 10-15% patients, AL amylodosis is associated with multiple 
myeloma. 
The organs most frequently affected by AL amyloidosis are kidney and 
Heart. The organ dysfunction is due to disruption of normal architecture by 
infiltrating amyloid fibrils. Renal involvement is manifested as nephrotic 
proteinuria with progressive worsening of renal dysfunction. Amyloidosis of 
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renal vasculature and tubulointerstitium usually present as renal failure without 
proteinuria. The clinical features includes congestive cardiac failure due to 
restrictive cardiomyopathy, hepatomegaly, carpal tunnel syndrome, skin 
nodules, arthropathy, macroglossia, periorbital odema, hoarseness of voice. The 
involvement of autonomic nervous system usually present as postural 
hypotension. Peripheral neuropathy presents as painful, bilateral symmetrical 
sensory symptoms, which could progress to motor weakness.  
The diagnosis of AL amyloidosis requires demonstration of tissue 
amyloid as well as plasma cell disorders. Tissue diagnoses are established by 
abdominal fat biopsy or renal biopsy and subject them to Congo-red stain to 
show apple green refringence. The confirmation of AL amyloidosis involves 
demonstration of plasma cell disorders by κ or λ producing clonal plasma cells 
in bone marrow or in urine and serum. The diagnosis and follow up of plasma 
cell dyscrasia is revolutionized by measurement of free light assay of κ, λ 
chains by nephelometric immuno assay. the normal serum levels of free light 
chains are 3.3-19.6mg/L for κ isotope and 5.5-26.3mg/L for λ isotype 
respectively. The normal ratio between κ and λ chains in the serum is between 
0.26-1.65.Since free light chains are free filtered by glomerulus, there is 
accumulation of free light chains in renal impairment,hence κ:λ ratio altered to 
0.37-3.1. a κ:λ ratio less than 0.26 suggests production of λ type of clonal 
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plasma cells, a ratio more than 1.65 strongly suggests κ type producing clonal 
plasma cells. 
The principles in treatment of AL amyloidosis is to rapidly reduce the 
burden of amyloidogenic protein from monoclonal light chains by suppressing 
plasma cell dyscrasia. The most effective treatment of AL amyloidosis is high 
dose melphalan followed by autologous peripheral stem cell transplantation. 
Supportive measures include coordinated care of multiple specialists. Achieving 
a balance between heart failure and intra vascular volume depletion is important 
in patients with autonomic dysfunction and nephrotic proteinuria. The treatment 
of amyloid renal disease includes salt restriction, diuretics and dyslipidemia 
control. Orthostatic hypotension is difficult to manage. Midodrine and waist 
high elastic stockings will be useful. The use of fludrocortisone is limited in 
view of fluid retention. 
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MATERIALS AND METHODS 
Ours is a  cross sectional descriptive study, done on elderly patients of 
age 60 or more years with clinical diagnosis of glomerular diseases and 
underwent renal biopsy in the department of Nephrology, Madras Medical 
College, Chennai, from August 2010 through December 2012. 
Exclusion criteria: 
1. Patients with age less than 60 years. 
2. Age more than 60 years with glomerular disease, biopsy not done. 
3. Age more than 60 years with biopsy proven non glomerular disease.  
The patients classified into five renal syndromes according the clinical 
presentations.  
1. Nephrotic syndrome: presence of 24 hour urine protein of more than 
3.5gms with or without odema, hypoalbuminemia, hyperlipidemia. 
2. Acute Nephritic syndrome: presence of red cell cast or dysmorphic 
RBC’s in urine microscopy with or without proteinuria, with odema, 
hypertension and decline in GFR. 
3. RPGN (Rapidly progressive Glomerulonephritis): A progressive 
and rapid decline in renal function developing over weeks to months 
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characterized by presence of RBC cast, hypertension, oliguria and 
azotemia. 
4. Acute kidney Injury: Increase in serum Creatinine within 7 days or 
0.3mg increase of Creatinine within 48 hours or Oliguria of less than 
0.5ml/kg/hr for 6 hours. 
5. Chronic kidney disease: Structural or functional abnormality of 
kidney lasting for more than 3 months. 
All suitable patients underwent detailed history and clinical 
examination, demographic and anthropometric data collection, urine 
analysis for protein, pus cells, active urinary sediments, spot urine 
protein-creatinine ratio, urine culture and sensitivity. Blood investigations 
include complete hemogram, renal function tests, liver function tests, 
fasting lipid profile, coagulation profile of bleeding time, clotting time, 
Prothrombin time done on all patients. Blood for ANA, AntidsDNA, Anti 
GBM antibodies, serum complement levels, ANCA, ASO titre, 
cryoglobulins, RA factor, serum electrophoresis, urine for Bence Jones 
proteins, Skeletal survey done in selected patients. All patients underwent 
ultrasonagram of the kidneys to ascertain the size before kidney biopsy. 
Written informed consent obtained from patients before renal biopsy. 
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Renal biopsy: 
In our department, renal biopsy is performed under ultrasound guidance 
with needle biopsy gun. Patient lies in prone position, with an upper abdominal 
support to splint the kidney; lower pole of the kidney is marked. After 
infiltration with 2% lignocaine, stab incision is made using a 11G blade. While 
asking the patient to hold breath, 16G biopsy needle gun is fired to get the 
sample. Patient is then asked to lie flat for 12 hours, with strict monitoring of 
pulse, blood pressure and urine output. Biopsy sample was sent in formalin & 
Michelle media for light microscopy (LM) and Immunoflourescence (IF) 
respectively. All the biopsy samples were reported by single nephropathologist 
to avoid bias. 
For LM, all samples were stained with hematoxylin and eosin (H&E), 
periodic acid -Schiff (PAS), Masson trichrome and Jones silver methenamine. 
For IF,3 µ sections were stained with florescent tagged antibodies to 
IgG,IgM,IgA,C3,C1q,fibrinogen,Kappa and lambda chains. 
Outcome measures: 
1. Complete remission: proteinuria less than 0.3gms per 24 hours 
2. Partial remission: proteinuria > 0.3 gms to 3.5gms per 24 hours or 
50% decline in proteinuria from its initial value. 
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3. No response: no decrease or worsening of proteinuria along with renal 
function. 
Statistical analysis: 
Baseline characteristics of all patients were presented descriptively with 
mean ± SD for continuous variables and percentage for categorical variables. 
We used Mann-Whitney test for univariate comparison of continuous variables 
and Fisher exact t test for categorical variables. Multivariate analysis was done 
by binary logistic regression analysis. p value of less than 0.05 was considered 
as statistically significant. It was performed using medcalc software. 
This study was approved by Institute Ethical committee of Madras 
Medical College 
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OBSERVATION AND   RESULTS 
Study population 
One hundred twenty six patients including 79 Males and 47 females 
(Male: Female ratio 1.7:1) were studied. Patients were stratified into different 
age groups as given below in table 1. 
Table 1-Demographic data 
Total number of patients  126 
Male: Female 79/47 (62%/38%) 
Mean Age ± SD 63.8 ± 2.9 years 
60-69 109 (86%) 
           70-79 14    (11.5%) 
           80-85 03    (2.5%) 
Co-morbid illness  
hypertension 44   (35%) 
Diabetes  21   (17%) 
Coronary artery disease 10   (8%) 
COPD 7     (5%) 
Hypothyroidism 4     (3%) 
 
Patients were classified depending upon the clinical presentations as 
given below in table 2.The most common clinical syndrome observed in our 
study is Nephrotic syndrome (46%), followed by acute nephritic syndrome 
(28%),acute kidney injury(18%) and RPGN (13%). 
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Table 2 Distribution clinical syndromes 
Clinical syndrome Number of patients  
Nephrotic syndrome 58     (46%) 
Acute Nephritic syndrome 28     (22%) 
RPGN 16     (13%) 
Acute Kidney injury 23   (18.3%) 
Chronic kidney disease 01     (0.7%) 
TOTAL 126 (100%) 
 
 Based on clinical, laboratory and histopathological evidences, we 
stratified our patients as those with primary or secondary glomerular diseases.  
 63% patients had secondary cause identified, of them predominantly 
were due to post infectious glomerular nephritis and vasculitis, (23% & 17%) 
respectively. 
 37% patients had primary glomerular diseases, which consists of 
Membranous nephropathy (MN) ( n=21),Focal Segmental Glomerulosclerosis 
(FSGS) (n=14), Minimal Change Disease(MCD) (n=5), IgA nephropathy 
(IgAN) (n=2), MembranoproliferativeGlomerulonephritis MPGN(n=2). 
 The sub classification and the percentage of presentation were 
explained in table 3. 
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Clinical presentation and histopathology correlation: 
Nephrotic syndrome: 
Nephrotic syndrome is the most common presentation (58 patients).It 
includes 42 patients with primary renal disease (72%) and 16 of secondary 
cause (28%). Membranous Nephropathy (n=21) and light chain disease(n=7) 
were commonest cause in both groups respectively. 
In primary renal disease, membranous nephropathy contributes 50% 
nephrotic syndrome in the elderly, followed by FSGS(33%),MCD(11%). 
 In systemic disease, presenting as nephrotic syndrome, light chain 
diseases comprises 44% of patients, followed by amyloidosis(25%). Two 
patients with hypertensive glomerulosclerosis and one patient, with SLE 
presented as nephrotic syndrome. one patient who had myeloid metaplasia 
presented with nephrotic syndrome, whose renal biopsy revealed hematopoietic 
elements within the glomerular capillaries, suggestive of a rare 
Myeloproliferative related Glomerulopathy. 
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Table 3. Clinical syndromes at presentation according to renal pathology. 
PATHOLOGY            NS            NNS       RPGN           AKI         CKD  SUM(%)
        PRIMARY RENAL
MINIMAL CHANGE 5 0 0 0 0 5   (4.5%)
MEMBRANOUS 21 0 0 0 0 21 (16%)
FSGS 12 0 0 2 0 14 (11%)
Ig AN 2 0 0 0 0 2   (1.5%)
MPGN 2 2 0 0 0 4   (3%)
SUBTOTAL  42 2 0 2 0 46 (36%)
          SYSTEMIC DISEASE
PIGN 1 22 3 2 0 28 (23%)
VASCULITIS 0 2 13 6 0 21 (17%)
LIGHT CHAIN DISEASE 7 0 0 8 0 15 (12%)
AMYLOIDOSIS 4 0 0 0 0 04 (3%)
HYPERTENSION 2 0 0 3 1 06 (5%)
SLE 1 2 0 0 0 03 (1,5%)
MISCELLANEOUS 1 0 0 2 0 03 (1.5%)
SUB TOTAL  16 26 16 21 1 80   ( 64%)
TOTAL 58(46%) 28(22%) 16(13%) 23(18.3%) 1(0.7%) 126(100%)
 
Table 4. Renal Histology in Nephrotic syndrome 
 Number   ( % ) 
Primary Glomerular diseases 42     (72%) 
      Membranous nephropathy 21 (36%) 
      FSGS 12 (21%) 
      Minimal change disease 05 (9%) 
      MPGN 02 (3%) 
       Ig A Nephropathy 02 (3%) 
Secondary Glomerular diseases 16 (28%) 
      Light chain disease 07 (12.5%) 
       Amyloidosis 04 (8%) 
       Hypertension 02 (3%) 
       SLE 01 (1.5%) 
       PIGN 01 (1.5%) 
 Myeloproliferative 
Glomerulopathy  
01 (1.5%) 
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ACUTE NEPHRITIC SYNDROME (n= 28) 
It includes 26 patients with secondary renal disease (92%) and only 2 of 
primary renal disease (8%). In primary renal disease, 2 patients with MPGN 
presented as acute nephritic syndrome. In systemic disease, post infectious 
glomerulonephritis(PIGN) comprises 80% of patients, followed by 
vasculitis(10%) and SLE(10%).In patients with ANS, 50% had 
hypertension,30% had nephrotic range of proteinuria,21% had crescents in the 
biopsy. 54% had serum creatinine of more than 1.5mg/dl. 20% had persistent 
renal dysfunction. 
Rapid Progressive Glomerulonephritis (n= 16) 
 In our study, all the 16 patients had secondary renal disease. 80% 
RPGN is caused by systemic vasculitis (n=13) followed by PIGN (n=3).50% 
had nephrotic range of proteinuria; mean creatinine at presentation was 
5.8mg/dl.50% had crescents in the biopsy. 60 % required hemodialytic support 
and 20% became dialysis dependent. Only 15% had complete recovery,65% 
developed  persistent renal dysfunction. 
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Acute Kidney Injury (n=23) 
 AKI was the third most common type of clinical syndrome observed. It 
includes 21 patients with secondary renal disease (92%) and only 2 of primary 
renal disease (8%). In primary renal disease, 2 patients with FSGS presented as 
AKI. In systemic disease, light chain diseases comprises 40% of patients, 
followed by vasculitis (30%), Hypertensive renal disease (15%), PIGN (15%). 
Chronic kidney disease (n=1) 
 One patient who had CKD with normal sized kidneys underwent 
biopsy, had hypertensive glomerulosclerosis.  
Clinical presentations and histopathology of major renal diseases: 
Membranous nephropathy: 
All 21 patients with MN presented as nephrotic syndrome. There were 13males 
& 8 females. Secondary cause of MN was identified in 5 patients (23%). 
[HBSAg 2, Rheumatoid arthritis,Malignancy of breast & stomach one each]. 
 70% patient falls under proteinuria range of 4-8 gms/day, 30% patients 
were in   the range of more than 8gms/day. The outcomes of patients with MN 
were analyzed in table 5. 2 patients with MN required dialytic support (one with 
crescentric transformation, other with malignancy).12 patients received only 
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ACE inhibitors (5 pts with secondary cause, 5 idiopathic). Remaining 9 patients 
were started on immunosupression with modified Ponticelli regimen. 7 out of 
21 patients subsequently lost follow up (30%), only 2 patients achieved 
complete remission (10%), 2 had no response, 2 died and 8 patients (30%) 
achieved partial remission. 
Table 5. Outcomes of Membranous Nephropathy 
Proteinuria 
range (gms) 
Mean 
Creatinine 
NO 
IS 
CR PR NR Lost 
follow 
up 
ESRD/ 
Death 
3-4           5 1.06 5 - 3 - 2 -
4-8 14 2.45 7 1 4 2 5 2 
>8 2 2.15 0 1 1 - 0 - 
               21          12 2 8 2 7 2 
 (CR-complete remission, PR-partial remission, NR - no response,                                      
NO IS- No immunosupression) 
Focal segmental Glomerulosclerosis: 
 14 patients had FSGS  (4 with diffuse mesangial proliferation).there 
were 11 males and three females.One had secondary FSGS (post donor 
nephrectomy1).  
 The outcomes of patients with FSGS were analyzed in table 6. 2 
patients required dialytic support (one with AKI, other diabetic presented with 
non diabetic renal disease).6 patients received only ACE inhibitors (2 pts with 
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secondary cause, 4 idiopathic).Remaining 7 patients were started on 
immunosupression with steroids.4 out of 14 patients subsequently lost follow up 
(30%), 3 patients achieved complete remission (20%), 3 had no response, 4 had 
partial response (30%) 
Table 6.Treatment outcomes of primary renal disease 
Diagnosis Number Secondary 
cause 
No  IS  CR PR NR Need for 
HD 
Lost  
F/U 
MCD 5 NIL 1 1 4 NIL NIL 1 
MGN 21 5 12 2 8 2 2 7 
FSGS 14 2 4 3 4 3 2 4 
MPGN 4 1 1 1 NIL 1 NIL NIL 
Ig A N 2 1 1 NIL 1 NIL 1 NIL 
TOTAL 46 9   
(20%) 
19 
(40%) 
7 
(15%) 
17 
(36%) 
6 
(12%) 
5 
(14%) 
12 
(26%) 
 40% patients were not initiated specific immunosuppressive therapy 
due to various reasons.26% patients lost subsequent follow up. Overall response 
rate is around 50% (complete remission 14%, partial remission 36%). 
Post infectious glomerulonephritis: 
 28 patients had PIGN. There were 16 males and 12 females. 
Hypertension and diabetes were present in 12(40%) and 3(10%) patients 
respectively.  77 % of patients presented as acute nephritic syndrome, followed 
by RPGN in 10%, AKI in 7%. One patient presented as nephrotic syndrome. 
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Table 7. Clinical and lab profile of patients with PIGN. 
Clinical features 
                                         No of patients    %  
Edema 26       99 
Oliguria 22       99 
Hypertension 12       74 
Macro hematuria 12       56 
Dialysis requiring renal failure 6        21 
Complete recovery 19      67 
Persistent renal dysfunction 7 25 
ESRD 2 8 
Laboratory Data                                                               
Nephrotic Proteinuria 18      60 
Sub nephrotic proteinuria 10      40 
   
Complements 
Low C3,C4 normal 
Low C3 & C4 
C3,C4 normal 
8/28      29 
6 
1 
1 
 
Serum Creatinine > 2mg/dl on admission 16      57 
Elevated ASO titre 18      60 
Table 8 presents detailed histopathological characteristics of renal biopsy in 
PIGN. 
 70% patients had diffuse endocapillary proliferation.12% had 
mesangial proliferation. 18% patients had crescentic glomerulonephritis, of 
them 50% had more than 30% crescents.25% patients had full house 
Immunoflourescence pattern. 16% had isolated C3 capillary wall deposits. Only 
one patient had IgA dominant pattern in IF.  
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Table 8. LM & IF patterns 
No of patients (%)  
Diffuse Proliferative GN 23  (70) 
Mesangio Proliferative GN  5   (12) 
Crescents  8   (18)  
       <30% of glomeruli  4  
        > 30% of glomeruli 4  
Immunofluorescence patterns                                
Full House 5  (25) 
C3/ IgG/IgM/C1q   3 (19) 
C3 & Ig G 10    (16) 
 C3 9  (16) 
Ig A dominant 1     (4) 
  20% patients required dialytic support. 67% patient’s attained 
complete recovery of renal function, 25% developed persistent renal 
dysfunction on follow up. Two of our patients became dialysis dependent 
(8%). 4 patients lost follow up. 
Vasculitis: 
 20 patients had features of vasculitis. Of these 18 were males, 3 
females. Hypertension and diabetes were present in 6(30%) and 7(35%) patients 
respectively.  55 % of patients presented as RPGN, followed by AKI in 25%, 
acute nephritic syndrome in 20%. The most common extra renal manifestations 
was seen in skin in 30% followed by pulmonary signs in 15%.the clinical and 
lab profile of patients is described in table 8. 
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Table 9. Clinical and lab profile of vasculitis 
Clinical features 
                                                  No of patients    %  
Edema 12 60 
Oliguria 18 90 
Skin lesions 6 30 
Pulmonary manifestations 3 15 
Macro hematuria 10 50 
Dialysis requiring renal failure 11 55 
Dialysis dependency/ESRD 3 15 
Death 3 15 
Complete recovery 1 5 
Persistent renal dysfunction 13 65 
Lost follow up 6 30 
Treatment    
  Prednisolone alone 11  
Pred + cyclophosphamide 07  
No therapy 3
Laboratory Data                                                                                       
Nephrotic Proteinuria 13 65 
Sub nephrotic proteinuria 07 35 
ANCA by IIF 
C ANCA 
P ANCA 
ANCA-NEG 
 
4 
5 
11 
 
20 
25 
55 
    
 Patients are classified according to Berden’s histopathological 
classification of vasculitis as shown in table 9. 35% had crescentic GN followed 
by focal proliferation in 25%, mixed GN & sclerotic GN constitutes 20% each. 
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Table 10 shows the histopathological classification of vasculitis 
 
Light Microscopy findings 
                                          No of patients (%)  
Focal Proliferative GN 5  (25) 
Crescentric GN  7   (35) 
Mixed  4  (20)   
Sclerotic   4   (20) 
     
55% patients required dialytic support. Only one attained complete recovery of 
renal function, 65% developed persistent renal dysfunction at discharge. 15% of 
patients became dialysis dependent and another 15% succumbed to death during 
first hospitalization. 30% lost subsequent follow up. 
AMYLOIDOSIS: 
 In our study, there were 6 patients with renal amyloidosis. All were 
males. All of them presented with nephrotic syndrome. Mean proteinuria was 
6.06gms/day. Mean creatinine was 2.1mg/dl. All the six, underwent 
investigations to rule out secondary cause. Two were found to have associated 
light chain disease. Two patients had AA amyloid deposits. (One-
bronchiectasis, other carcinoma colon). Two patients who had AL type of 
amyloidosis with negative screening for myeloma. One of such patient 
underwent donor nephrectomy 20 years before, cause could not be found out. 
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DISCUSSION 
     Our study demonstrates the various spectrums of glomerular 
diseases in elderly population. Males(65%) predominates females(34%) in this 
study, which could be due to relatively lesser number of female patients being 
referred to our tertiary care centre. In the age range, 86% patients belong to 
range of 60-69years, 11% of 70-79 years and 3% were more than 80 years 
respectively. 
Indications for Renal Biopsy 
The most common indication for renal biopsy in this study is Nephrotic 
Syndrome (46%), followed by acute nephritic syndrome (22%), AKI (18%), 
RPGN (13%), CKD (1%). In studies by Hass et al, Nair et al and Uezeno et al   
acute kidney injury was the commonest indication, followed by Nephrotic 
syndrome[4][14][19]. Chronic Kidney disease and Asymptomatic Urinary 
Abnormalities (AUA) constitutes about 10% each. In study from Italian renal 
biopsy registry, asymptomatic urinary abnormalities were the commonest 
indication for the renal biopsy[47]. The lesser prevalence of CKD and AUA 
could be attributed to late referral of patients to our tertiary care centre. 
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CLINICAL SYNDROMES
AUTHOR Moutzouris et al  Davison et al  Rivera et al Present 
Country US 2009[18] UK 1996 [48] Spain2004[49] study
No of patients 235 750 2100 126
NEPHROTIC SYNDROME 13% 31% 36% 46%
NEPHRITIC SYNDORME 9% 10% 17% 35%
ACUTE KIDNEY INJURY 46% 26% 26% 18%
PROGRESSIVE CKD 24% 25% 19% 1%
ASYMPTOMATIC U A 6% 8% 12% ND  
Nephrotic Syndrome: 
In our study, primary renal disease accounts for 73% nephrotic syndrome, 
whereas one third of the cases were due to secondary glomerular diseases. This 
is in concordance with previous studies. 
Among the primary glomerular disease, commonest causes in the 
descending order are Membranous nephropathy (36%) FSGS (21%), MCD 
(9%), IgAN (3%),  MPGN(3%) respectively. This results were comparable with 
largest ever study done in elderly population by Rivera et al in 725 patients who 
reported MN (36%), MCD(13%), FSGS (10%), MPGN(7%) respectively[49]. 
Several studies have confirmed that commonest cause of nephrotic syndrome in 
elderly population is membranous nephropathy which is often idiopathic. In this 
present study, one fourth of our patients had a secondary cause. Two patients 
had chronic hepatitis B infection, one patient with rheumatoid arthritis, two 
patients with solid organ malignancy (Carcinoma stomach & breast). FSGS 
represents second most common cause of nephrotic syndrome in our study 
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accounting for 21% patients. This is in contrast to other studies. One possibility 
is that it may represent certain unrecognized secondary pathologies like 
hypertensive glomerulosclerosis or obesity. 
In the secondary glomerular disease, commonest causes in the descending 
order are light chain diseases (12%) amyloidosis (8%),) diabetes (5%) and 
hypertensive glomerulosclerosis (4%) respectively. This is in contrast to other 
studies, where commonest cause of secondary glomerular disease is diabetic 
nephropathy and amyloidosis. Though diabetes is increasingly prevalent in our 
population, our protocol to do renal biopsy in diabetes is only when we suspect 
non diabetic renal disease. This restrictive approach explains the low prevalence 
diabetic nephropathy in this study. 
Acute Nephritic Syndrome (ANS): 
The second commonest clinical presentation in our study is acute 
nephritic Syndrome, accounting 22% of patients. In studies from developed 
countries, ANS contributes only to 4.7% of clinical syndrome. An Indian study 
by Jaiprakash et al[50] showed 29% of prevalence of ANS which is comparable 
with our data. 
92% patients with ANS were due to secondary glomerular disease, 
commonest being post infectious Glomerulonephritis (PIGN), followed by 
Vasculitis and SLE. In developing countries like India, infection related renal 
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diseases continue to be widely prevalent. This is related to low socioeconomic 
status, poor hygienic conditions and high incidence of diabetes. 
Rapidly Progressive Glomerulonephritis:  
In our series, 13% of patients had RPGN. All the 16 patients had 
secondary glomerular disease, most common being Vasculitis followed by 
PIGN. In a study by Moutzouris et al, the most common cause of crescentric 
GN in elderly population is vasculitis (80%) [18].Our study showed similar 
prevalence (81%).This is in contrast to other Indian study by Jaiprakash et al, 
whose study reported 100% RPGN due to infectious GN, none of his patients 
had vasculitis [50]. 
Acute Kidney Injury: 
In our study, 18.3% of patients presented with AKI. The commonest 
causes in descending order were Light chain diseases (38%), Vasculitis (30%) 
and Hypertensive glomerulosclerosis (15%).Though in the western literature, 
vasculitis is predominant finding in a elderly patient with AKI, cases of 
Thrombotic Microangiopathy, Good Pasture syndrome, Cryoglobulinemic GN 
were seen in common proportions, which are not seen in our series.  
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Post infectious glomerulonephritis: 
PIGN is still the most common cause of glomerulonephritis in the 
developing world. In this series, PIGN is the most common disorder observed, 
accounting for 23% of patients (n=28).  In a study in general population, 
Baldwin et al [32] and Chugh et al [51] published long term follow-up of 
poststreptococal glomerulonephritis patients for 60 months and 4.5 yrs 
respectively. Irreversible renal disease, as evidenced by hypertension (42%), 
proteinuria (42%), decreased renal function (38%) or glomerulosclerosis (10%) 
was reported by former and persistent hypertension (15%), ESRD (1.9%) and 
chronic renal failure (3.8%) were observed in the latter study. In an exclusive 
study of PIGN in elderly patients, Nasr et al studied 109 patients with follow up 
of 29 months, 22% achieved complete renal recovery, 44% had persistent renal 
dysfunction, and 33% progressed to ESRD. 60% had immunocompromised 
background in the form of diabetes or malignancy [25]. 
 In our study, 20% patients required dialytic support. 67% patients 
attained complete recovery of renal function, 25% had persistent renal 
dysfunction on follow up. Two of our patients became dialysis dependent (8%). 
4 patients lost follow up. Only 10% patients were diabetic, none had 
malignancy. This explains the better renal outcome in our patients, when 
compared with study by Nasr et al. 
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AUTHOR Moroni et al Baldwin et al Nasr et al Chugh et al  Present
PERIOD 1976‐96 1976 2009 1987 STUDY
COUNTRY ITALY US US INDIA
NO OF PATIENTS 50 168 109 142 28
MEAN AGE 54YRS 45                      7                 40 Y 64.5YRS
DIABETES 10%                      NA 49%                       N 10%
CR 43% 73% 22% 58% 67%
PRD 47% 23% 44% 28% 25%
ESRD 10% 4% 33% 14% 8%
 
 We did a univariate analysis by Fisher exact test as explained in table13, 
to predict the recovery of renal function. The factors which had statistical 
significance were peak creatinine at the time of biopsy of more than 4.3mg/dl, 
need for hemodialytic support,presence of crescents in the biopsy. Sex, Amount 
of proteinuria, presence of diabetes and hypertension did not have statistical 
significance. 
 Analyzing  the variables which high statistical significance by univariate 
analysis using binary logistic multiple regression model to find out independent 
risk factors, only peak creatinine level had a statistical significance, p value 
0.012, (95% confidence interval 0.044 to 0.03352).  
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Table 13            Predictors of renal recovery: univariate analysis 
Variables Complete 
renal recovery
(n=19) 
Persistent renal 
dysfunction 
(n=9) 
p value 
Sex (M:F) 11:8  5:4 1.00(ns) 
Diabetes 1 2 0.234(ns) 
hypertension 10 3 0.432(ns) 
Mean proteinuria 2.17±1.52 6.01 ±2.45 0.081 
Mean creatinine 2.2 ± 0.21 4.3 ± 0.43 0.001 
Dialytic support 0 4 0.007 
Presence of crescents 1 4 0.025 
Vasculitis:  
 In the West, pauci immune necrotizing glomerulonephritis is the most 
frequent biopsy finding in an elderly patient presented with acute kidney injury. 
Several studies have demonstrated poor prognosis for older patients with 
mortality rate 25% within first year of diagnosis and higher incidence of ESRD 
and treatment related complications when compared to young[45]. In India, data 
on vasculitis is scarce and thought to be uncommon. In study by Sakhuja et al 
from PGI Chandigarh, only 2% biopsies (n=48) over a period of 8 years had 
pauci immune vasculitis [52]. Our series found pauci immune glomerulonephritis 
is second only to PIGN, contributing 17% of biopsy diagnosis. 
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 In this study, most of the patients presented with severe renal failure 
(mean creatinine6.12mg), 55% required dialytic support. Only 15 to 30% had 
extra renal features like skin rash and pulmonary manifestations. Only 50% 
patients were ANCA positive(C-ANCA & P-ANCA 25% each). On analyzing 
the outcomes, 15% died during initial admission, 15% became dialysis 
dependent,65% though become dialysis independent had persistent renal 
dysfunction, only one patient had complete recovery(5%). Patients with severe 
glomerulosclerosis and tubular atrophy in the biopsy were not given cytotoxics 
and hence only 35% received steroids and cyclophosphamide. 50% received 
steroids alone. 30% lost subsequent follow up. 
 In an exclusive study on AAV in elderly age group of more than 80 
years, Bomback et al reported 78 patients. Only 40% had extra renal features 
similar to our study. Only 50% were started on steroids and cytotoxics. Overall 
70% patients reach ESRD or death within the first year of diagnosis. no 
difference in the mortality rate were found at 1 year between those treated with 
immunosupression and non immunosupression, but on extending the follow up 
to two years, marginal survival benefit was found with immunosupression 
group[45]. 
 Berden et al classified AAV based on histopathological features into 
four patterns and it’s been validated to predict renal survival. The prevalence of 
53 
 
focal, crescentric, mixed and sclerotic were 15%,55%,16%,13% respectively, 
with renal survival at 1 year of 93%,84%,69% and 50% in the same order[46]. In 
our series, the prevalence of focal, crescentric, mixed and sclerotic pattern were 
25%, 35%, 20% and 20% respectively. 
Outcomes of Nephrotic Syndrome: 
Several studies have reported that many patterns of nephrotic syndrome 
in elderly, as in younger patients are responds to treatment and have good 
prognosis and outcomes. 
Membranous Nephropathy: 
In our study of 21 patients with MN, patients with secondary causes and 
less than 4gms of proteinuria per day were treated with ACE inhibitors alone. 
Hence only 50% patients received immunosuppressive therapy. Overall 10% 
achieved complete remission, 40% partial remission. 10% had no remission. 
About 40% lost subsequent follow up. Two patients who HBV related 
nephropathy had complete remission following antiviral therapy. In a study 
from Japan, komatsuda et al reported favourable outcomes in 90% of elderly 
membranous nephropathy. But studies from Europe had remission rate of 40 to 
50%. The good outcome in Japanese has been attributed to presence HLA-DR2 
in those patients[53]. 
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Minimal change disease: 
In our study of 5 patients with MCD, one patient had complete remission, 
4 had partial remission. None of our patients had secondary cause. One patient 
was not started on steroids. 
Focal segmental glomerulosclerosis: 
 Out of 14 patients with FSGS, six patients received only ACE 
inhibitors (1pt with secondary cause, 4 idiopathic). Others were started on 
immunosupression with steroids.  4 out of 14 patients subsequently lost follow 
up (30%), 3 patients achieved complete remission (20%), 4 had partial response 
(30%), 3 had no response. 
Amyloidosis: 
 In studies from Italian[47] and Spanish[49] renal registry, amyloidosis 
constitutes major proportion of nephrotic Syndrome, around 20%. Jaiprakash et 
al from India has reported 15% nephrotic syndrome due to amyloidosis, all 
related to leprosy[50]. In our series, 6 patients (5%) had amyloidosis. None had 
Hansen’s disease. Two has associated light chain disease, 2 had evidence of 
malignancy.  
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Usefulness of renal biopsy in the elderly: 
 Our study reconfirms the usefulness of renal biopsy in the elderly 
patients in the diagnosis and management of renal disease, specifically in cases 
of rapidly progressive glomerulonephritis, acute kidney injury and nephrotic 
syndrome. Nair et al has reviewed the importance of renal biopsy in the elderly 
[14]. He reported in 40 out of 100 patients, potentially treatable conditions like 
crescentric GN, membranous nephropathy, minimal change disease, light chain 
diseases, thrombotic microangiopathy and acute interstitial nephritis. In the rest, 
it serves as a prognostic marker and protects the patients from empirical 
cytotoxic therapy. This statement has been validated in our study. In our 
patients with vasculitis and nephrotic syndrome, nearly 40% did not receive 
cytotoxics in view of severe chronic changes. But for renal biopsy, they would 
have been started on cytotoxic drugs. 
Our study provides epidemiological background of glomerular diseases in 
elderly in our population to plan for future studies on treatment outcomes. 
Limitations of our study: 
1. Our study represents only the patients referred to a tertiary care centre 
with significant illness. Many patients with asymptomatic urinary 
abnormalities would have been left out. 
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2. The patients with clinical and laboratory evidence of glomerular 
disease but without renal biopsy due to medical or logistic reasons 
were not included. 
3. Mean follow up period is only two years. 
4. Significant numbers of patients (26%) were lost in the follow up. This 
could be an important confounding factor in assessment of renal 
outcomes. 
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CONCLUSION 
1. 64% of  glomerular diseases were due to secondary causes, primary 
renal disease contributes to about 36% 
2. The most common cause of glomerulonephritis in our setup is post 
infectious glomerulonephritis, which contributes to 23% cases.  
3. Vasculitis is the second most common cause glomerulonephritis in our 
elderly population, comprising 17% patients. 
4. Membranous nephropathy is the most common cause of nephrotic 
syndrome in our study accounting for 16% total cases and 46% of 
patients with nephrotic syndrome. 
5. One fourth of membranous nephropathy is due to secondary cause. 
Hence it is important to screen for chronic infections, malignancy and 
systemic illness in a newly detected patient with membranous 
nephropathy. 
6. In contrast to other studies, minimal change disease is less common in 
elderly population in our study; On the contrary there is high 
prevalence of FSGS. 
7. Patients with PIGN had better renal outcomes in our series when 
compared to other studies. 65% had complete recovery, 25% had 
persistent renal dysfunction and 10% developed ESRD. On univariate 
analysis, peak creatinine of more than 4mg at presentation, need for 
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dialytic support and the  presence of crescents in biopsy were found to 
have statistically significance. In multivariate analysis, only peak 
creatinine at presentation had  statistical significance. 
8. In patients with Vasculitis, the outcome was poor.15% died on initial 
admission, 30% became dialysis dependent, 30% had persistent renal 
dysfunction and only 5% made complete recovery. 
9. Outcomes of nephrotic syndrome is not easy to assess in our 
population, since  40% were not started on immunosupression due to 
co morbid illness and about 25% were not on regular follow up. 
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AMYLOIDOSIS 
CONGO RED STAINING   SHOWING SALMON‐ORANGE RED COLOUR IN LIGHT MICROSCOPY 
 
 
VASCULITIS –H& E STAIN showing fibrinoid necrosis of blood  vessel,  partial cellular crescent in 
glomeruli 
 
 
   
Post infectious Glomeulnephritis 
 H &E STAIN  
 Diffuse proliferative GN with crescents & neutrophillic infiltration 
 
Membranous Nephropathy 
Silver methenamine staining showing pin hole lesions  
 
 
SPECTRUM OF GLOMERULAR DISEASE  IN ELDERLY 
NAME:                                                                             AGE/SEX              NC NO:                             
WT:            HT: 
PHONE NUMBER: 
CO MORBID STATUS:         DM        HTN          CAD       CVA         COPD 
RENAL SYNDROME  :     
 
EXTRA RENAL SYMPTOMS: 
CARE GIVER: 
SOCIOECONOMIC STATUS: 
MOBILITY: 
COGNITION: 
SLEEP: 
NUTRITION: 
DRUGS: 
Investigations : 
 
Sl No. Test     
1 ECG    
2 TC    
3 DC    
4 ESR    
5 Hb    
6 UREA    
7 CREATININE    
8 B.SUGAR    
9 Sr Na    
10 Sr K    
11 Sr Po4    
12 Sr calcium    
13 Sr uric acid    
14 Sr osmolality    
   
15 ABG    
   
   
   
16 URINALYSIS    
 Protein    
Sugar    
Deposits    
32      X ray KUB    
33 USG  
 
 
  
34 CT KUB    
35 ANCA    
36 C3    
37 C4    
38 ASO TITRE    
39     
40     
 
eGFR: 
RENAL BIOPSY/ COMPLICATIONS IF ANY: 
NO  OF GLOMERULI 
% GLOBALLY SCLEROTIC GLOMERULI 
% GLOMERULI WITH CRESCENTS 
% TUBULAR ATROPHY/INTER FIBROSIS 
% INTERSTITIAL INFLAMMATION 
% VASCULAR DISEASE 
IMMUNOFLOURESCENCE 
TREATMENT:        
 
 


